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In the last decade biomaterials have increasingly been studied as the next generation of 
immunotherapeutic treatments for their tendency to induce host response against themselves 
when implanted. Addressing this significant barrier of host response is a key step in engineering 
our immune response to target foreign invaders and diseases such as cancer. A promising 
application of this is gold nanoparticle’s (AuNPs) ability to interact with dendritic cells (DCs) in 
our bodies. 
When the immune system responds to a threat in the body, it initiates a twofold response. 
The innate and adaptive immune responses respond with different approaches to establish 
immunity in the body, but ultimately work in partnership with each other to optimize the 
response pathway. While the innate response is immediate and nonspecific to the antigens of 
importance, the adaptive immune response takes several weeks to developed, but provides a 
tailored response to the antigens present. The adaptive immune response functions through T and 
B lymphocytes; allowing the body to retain memory in the form of a chemical structure copy of 
the antigen of importance. This memory allows the body to later elicit a quicker response to 
foreign invader upon subsequent exposure. Dendritic cells of the immune system are responsible 
for mediating both of these reaction pathways.  
 AuNPs show high potential in the field of immunotherapies because they act as an 
adjuvant to evoke immuno-suppressive or immuno-activated response depending on their 
geometries and ligand coatings. The role of dendritic cells is to work as a gatekeeper to initiating 
immune response in our bodies as they are the most potent antigen presenting cell (APC). In 
previous research, it has been shown that AuNPs can trigger the maturation of immature 
dendritic cells (iDCs) to activated or tolerogenic phenotypes.  
Researchers continue to fine tune nanoparticle technology for personalized 
immunotherapies and data indicates the efficacy of AuNP in eliciting anti-tumor response and a 
providing a superior method to apply targeted vaccinations. ,  As the potential for clinical 
application becomes increasingly apparent, we must dive deeper into the pathophysiology of the 
tumor environment and subsequently question the relevance of these findings.  
The host environments’ interaction with the tumor is one of the most important factors in 
cancer modeling.  In this study we investigate effectiveness of AuNP application in the presence 
of tumor microenvironment equip with dendritic cells, macrophages, and fibroblasts. We 
iteratively preform co-cultures of MCF-7 breast cancer cells with every combination of these 
cells in order to create a schematic which will assess applicability of AuNP use in breast cancer 
models. To make this assessment we will run tests to determine cell growth, viability, metastasis, 
and susceptibility to drugs. 
 
LITERATURE REVIEW 
Dendritic cells are created and cultivated by differentiation in specific bone marrow cells 
called monocytes.  When an immune response occurs in the body, monocytes will cluster at the 
site of inflammation and systematically develop into immature dendritic cells (iDCs). Their 
major role in the innate and adaptive pathways is the activation of T cells.  Antigens are 
presented to immature dendritic cells, the iDCs phagocytose the antigens, and present the 
antigens on their surface. Once the antigens are presented on the surface of these cells the 
classification changes from immature to mature.  
In the last decade, nanoparticles have been a major area of focus for many researches as 
they show potential to carry and delivery drugs with very specific targeting, due to their low cell 
toxicity. Additionally, they show promise in the augmentation of the maturation of dendritic 
cells. Controlling the phenotype displayed in a mature dendritic cell allows for engineering and 
manipulation of the body’s immune response.  
Changes in nanoparticle size, shape, and coating have been shown to majorly skew the 
effectiveness of such treatments. Treated on a wide range of cell types, gold nanoparticles 
(AuNPs) in rod shapes with diameters of approximately 55nm seem to be the most effective in 
cell targeting.  This is a good starting point for functionalization of NPs, but studies indicate 
that they should be further functionalized on a by-cell basis. For example, studies have shown 
that folic acid (FA) increased AuNP uptake in tumor cells because they over express folate 
receptors on their surfaces.  As we dig into how the functionalization of a NP determines its 
effectiveness, it becomes clear that the cells’ microenvironment is just as important as cell type, 
if not more important, to determine binding efficiency.  
3D extracellular matrices modulate intercellular interactions such as cell growth and 
metastasis.  Additionally, no tumor cell is purely one cell type. Fibroblast, dendritic cells, and 
monocytes are all part of the mix. Co-cultivation of these cell types into 3D spheroids produce 
protein concentrations analogous to tumors, while 2D models do not.  Studies have actually 
shown that spheroids are produced are predictably and analogous to one another and to actual 
tumors when co-cultured with fibroblasts.  
MCF-7 breast cancer cells are one of the most commonly used breast cancer cell lines for 
research, because they react similarly to breast cancer cells in the body and they can be 
functionalized to be drug resistant to cancer therapies.  They are fairly adherent cells and have a 
karyotype of 69 chromosomes.  Spheroid cultivation of MCF-7 cells can be done in a variety of 
methods include ultra low attachment (ULA) plates and embedment in Matrigel and show better 
results than other cell lines.  Additionally, these methods allow for easy co-culture of MFC-7 
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In the last decade biomaterials have increasingly been studied as the next generation of 
immunotherapeutic treatments for their tendency to induce host response against themselves 
when implanted. Addressing this significant barrier of host response is a key step in engineering 
our immune response to target foreign invaders and diseases such as cancer. A promising 
application of this is gold nanoparticle’s (AuNPs) ability to interact with dendritic cells (DCs) in 
our bodies. 
When the immune system responds to a threat in the body, it initiates a twofold response: 
innate and adaptive immune responses. Each respond simultaneously with different approaches 
to establish immunity in the body, but they ultimately work in partnership with each other to 
optimize the response pathway. While the innate response is immediate and nonspecific to the 
antigens of importance, the adaptive immune response takes several weeks to develop, but 
provides a tailored response to the antigens present. The adaptive immune response functions 
through T and B lymphocytes; allowing the body to retain memory in the form of a chemical 
structure copy of the antigen of importance. This memory allows the body to later elicit a quicker 
response to foreign invader upon subsequent exposure. Using a similar, antigen presenting 
mechanism, dendritic cells of our body are responsible for mediating both of these reaction 
pathways that comprise the immune system." 
 AuNPs show high potential in the field of immunotherapies because they act as an 
adjuvant to evoke immuno-suppressive or immuno-activated response depending on their 
geometries and ligand coatings. The role of dendritic cells is to work as a gatekeeper to initiating 
immune response in our bodies as they are the most potent antigen presenting cell (APC). In 
previous research, it has been shown that AuNPs can trigger the maturation of immature 
dendritic cells (iDCs) to activated or tolerogenic phenotypes.# 
Researchers continue to fine tune nanoparticle technology for personalized 
immunotherapies and data indicates the efficacy of AuNP in eliciting anti-tumor response by 
providing a superior method to apply targeted vaccinations.$,& As the potential for clinical 
application becomes increasingly apparent, we must dive deeper into the pathophysiology of the 
tumor environment and subsequently question the relevance of these findings.  
Dendritic cells are created and cultivated by differentiation in specific bone marrow cells 
called monocytes.' When an immune response occurs in the body, monocytes will cluster at the 
site of inflammation and systematically develop into immature dendritic cells (iDCs). Their 
major role in the innate and adaptive pathways is the activation of T cells.( Antigens are 
presented to immature dendritic cells, the iDCs phagocytose the antigens, and present the 
antigens on their surface. Once the antigens are presented on the surface of these cells the 
classification changes from immature to mature.) 
The host environments’ interaction with the tumor is one of the most important factors in 
cancer modeling.* In this study we investigate the effectiveness of AuNP application in the 
presence of tumor microenvironment equipped with dendritic cells, macrophages, and 
fibroblasts. We iteratively perform co-cultures of MCF-7 breast cancer cells with every 
combination of these cells in order to create a schematic which will assess applicability of AuNP 
use in breast cancer models. To make this assessment we will run tests to determine cell growth, 
viability, metastasis, and susceptibility to drugs. An indication of AuNPs working to combat 
cancer cells would be decreased cell growth, viability and metastasis and an increased 
susceptibility to drugs. 
LITERATURE REVIEW 
In the last decade, nanoparticles have been a major area of focus for many researches as 
they show potential to carry and deliver drugs with very specific targeting, due to their low cell 
toxicity. Additionally, they show promise in the augmentation of the maturation of dendritic 
cells. Controlling the phenotype displayed in a mature dendritic cell allows for engineering and 
manipulation of the body’s immune response.+ 
Changes in nanoparticle size, shape, and coating have been shown to majorly skew the 
effectiveness of such treatments. Treated on a wide range of cell types, gold nanoparticles 
(AuNPs) in rod shapes with diameters of approximately 55nm seem to be the most effective in 
cell targeting.", This is a good starting point for functionalization of NPs, but studies indicate 
that they should be further functionalized on a by-cell basis. For example, studies have shown 
that folic acid (FA) increased AuNP uptake in tumor cells because they overexpress folate 
receptors on their surfaces."" As we dig into how the functionalization of a NP determines its 
effectiveness, it becomes clear that the cells’ microenvironment is just as important as cell type, 
if not more important, to determine binding efficiency.  
3D extracellular matrices modulate intercellular interactions such as cell growth and 
metastasis."# Additionally, no tumor cell is purely one cell type. Fibroblast, dendritic cells, and 
monocytes are all part of the mix. Co-cultivation of these cell types into 3D spheroids produce 
protein concentrations analogous to tumors, while 2D models do not."$,"&  
The presence of these ECMs create a significant damper on AuNP delivery in vivo. A 
study preformed at the Indian Institute of Technology in Kanpur showed that the maximum 
achievable efficiency in vivo is only 2%. Although most of the NPs in this study were removed 
by Kupffer cells and other macrophages in the liver, NPs were also observed to pile up around 
the perivascular region. This “stockpile” was counterproductive to the deep diffusion of AuNPs 
into the tumor space because the extracellular matrices of the tumors block NP diffusion in a size 
dependent manner."'   
MCF-7 breast cancer cells are one of the most commonly used breast cancer cell lines for 
research, because they react similarly to breast cancer cells in the body and they can be 
functionalized to be drug resistant to cancer therapies."( They are fairly large adherent cells and 
have a karyotype of 69 chromosomes.") MCF-7 cells have the ability to process estrogen, 
therefore they are estrogen sensitive. The typical cell size of an MCF-7 cell is 20-25 microns and 
typically are cultured in Eagle’s Minimum Essential Medium (EMEM).  When grown in vitro, 
the epithelial like cells of the culture will grow in monolayers while other cells can produce 
dome-like shapes. Spheroid cultivation of MCF-7 cells can be done in a variety of methods 
include ultra-low attachment (ULA) plates and embedment in Matrigel and show better results 
than other cell lines.* Additionally, these methods allow for easy co-culture of MFC-7 cells.   
MCF-7 cells are often manipulated to be drug-sensitive to doxorubicin, a chemotherapy 
drug, or doxorubicin-resistant."* Many studies investigate these drug-differentiated phenotypes 
of MCF-7 cells with their surroundings; such as the study performed by Professor Mougel’s team 
in France- it investigated the effects on immune reactivity of MCF-7 cells by monocytes. The 
study found that, according the phenotype of the breast cancer spheroid, monocytes respond with 
differential recruitment and behavior towards the masses."+ The type of monocyte that is of 
particular interest of those in the immune-reactivity field is a macrophage cell. Recent literature 
suggests that in tumor environments there is an important “cross-talk” that is occurring between 
breast cancer cells and macrophages. Donzelli noted the increase in angiogenesis as a result of 
signaling proteins being exchanged between the two cell types.#, The other major constituent of 
breast cancer stroma is fibroblasts. Research indicates that both fibroblasts and macrophages 
cooperate to organize co-cultures into tumor spheroids in vitro. Rama-Esesndagli’s group found 
that not only was there a higher frequency of spheroids formed when using co-cultures rather 
than just breast cancer cells, but these spheroids also exhibited a higher cellular density than their 
counterparts and are more analogous to each other."& 
 
MATERIALS AND METHODS 
This investigation is multifaceted in terms of experimental setup. First, the proper 
Matrigel concentration for the formation of MCF-7 spheroids must be confirmed. MCF-7 Cells 
will be plated at varying cell concentrations in mediums with varying composition of Matrigel to 
investigate which method most reliably produces spheroids. See the below plate layout for more 
information. 
 
Figure 1: Plate layout for determining optimal Matrigel concentration 
Cell viability will be assessed both optically (through the use of a microscope with the capability 
to take photographs and by using a Cell-Titer Glo 3D Cell Viability assay. The Cell-Titer Glo 3D 
Cell Viability assay will be performed as instructed by Promega, the distributor.  
 The next experiment to be performed will be adding AuNP treated dendritic cells to the 
MCF-7 cells in Matrigel to create a coculture of the two. Dendritic cells will be treated with 
AuNPs per the protocol perfected by another group of undergraduates in Dr. Babensee’s lab. 
(their paper will eventually be linked here, but it has not been published yet). Subsequently, 
macrophages will be added to the coculture and then fibroblasts native to human breast tissue. 
Assays will be conducted to determine cell growth, viability, metastasis, and susceptibility to 
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D. Madden’s Comments: 
 
Kalyn, your intro is really fantastic and is in good shape. Very rarely does this happen, but I don't have comments right 
now. We'll go over next steps in our meeting. 




 Change the sentence structure of one sentence in the literature review. We stopped the sentence at the hyphen and broke 
it into two sentences. 
 
 
Comments from my advisor: 
Dr. Babensee commented a lot on my first proposal and has not made any comments sense 
then. There is no record of those comments, because I was not aware that we were supposed 
to save them. She talked very fast and we made the changes as she talked. 
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In the last decade biomaterials have increasingly been studied as the next generation of 
immunotherapeutic treatments for their tendency to induce host response against themselves 
when implanted. Addressing this significant barrier of host response is a key step in engineering 
our immune response to target foreign invaders and diseases such as cancer. A promising 
application of this is gold nanoparticle’s (AuNPs) ability to interact with dendritic cells (DCs) in 
our bodies. 
When the immune system responds to a threat in the body, it initiates a twofold response: 
innate and adaptive immune responses. Each respond simultaneously with different approaches 
to establish immunity in the body, but they ultimately work in partnership with each other to 
optimize the response pathway. While the innate response is immediate and nonspecific to the 
antigens of importance, the adaptive immune response takes several weeks to develop, but 
provides a tailored response to the antigens present. The adaptive immune response functions 
through T and B lymphocytes; allowing the body to retain memory in the form of a chemical 
structure copy of the antigen of importance. This memory allows the body to later elicit a quicker 
response to foreign invader upon subsequent exposure. Using a similar, antigen presenting 
mechanism, dendritic cells of our body are responsible for mediating both of these reaction 
pathways that comprise the immune system." 
 AuNPs show high potential in the field of immunotherapies because they act as an 
adjuvant to evoke immuno-suppressive or immuno-activated response depending on their 
geometries and ligand coatings. The role of dendritic cells is to work as a gatekeeper to initiating 
immune response in our bodies as they are the most potent antigen presenting cell (APC). In 
previous research, it has been shown that AuNPs can trigger the maturation of immature 
dendritic cells (iDCs) to activated or tolerogenic phenotypes.# 
Researchers continue to fine tune nanoparticle technology for personalized 
immunotherapies and data indicates the efficacy of AuNP in eliciting anti-tumor response by 
providing a superior method to apply targeted vaccinations.$,& As the potential for clinical 
application becomes increasingly apparent, we must dive deeper into the pathophysiology of the 
tumor environment and subsequently question the relevance of these findings.  
Dendritic cells are created and cultivated by differentiation in specific bone marrow cells 
called monocytes.' When an immune response occurs in the body, monocytes will cluster at the 
site of inflammation and systematically develop into immature dendritic cells (iDCs). Their 
major role in the innate and adaptive pathways is the activation of T cells.( Antigens are 
presented to immature dendritic cells, the iDCs phagocytose the antigens, and present the 
antigens on their surface. Once the antigens are presented on the surface of these cells the 
classification changes from immature to mature.) 
The host environments’ interaction with the tumor is one of the most important factors in 
cancer modeling.* In this study we investigate the effectiveness of AuNP application in the 
presence of tumor microenvironment equipped with dendritic cells, macrophages, and 
fibroblasts. We iteratively perform co-cultures of MCF-7 breast cancer cells with every 
combination of these cells in order to create a schematic which will assess applicability of AuNP 
use in breast cancer models. To make this assessment we will run tests to determine cell growth, 
viability, metastasis, and susceptibility to drugs. An indication of AuNPs working to combat 
cancer cells would be decreased cell growth, viability and metastasis and an increased 
susceptibility to drugs. 
LITERATURE REVIEW 
In the last decade, nanoparticles have been a major area of focus for many researches as 
they show potential to carry and deliver drugs with very specific targeting, due to their low cell 
toxicity. Additionally, they show promise in the augmentation of the maturation of dendritic 
cells. Controlling the phenotype displayed in a mature dendritic cell allows for engineering and 
manipulation of the body’s immune response.+ 
Changes in nanoparticle size, shape, and coating have been shown to majorly skew the 
effectiveness of such treatments. Treated on a wide range of cell types, gold nanoparticles 
(AuNPs) in rod shapes with diameters of approximately 55nm seem to be the most effective in 
cell targeting.", This is a good starting point for functionalization of NPs, but studies indicate 
that they should be further functionalized on a by-cell basis. For example, studies have shown 
that folic acid (FA) increased AuNP uptake in tumor cells because they overexpress folate 
receptors on their surfaces."" As we dig into how the functionalization of a NP determines its 
effectiveness, it becomes clear that the cells’ microenvironment is just as important as cell type, 
if not more important, to determine binding efficiency.  
3D extracellular matrices modulate intercellular interactions such as cell growth and 
metastasis."# Additionally, no tumor cell is purely one cell type. Fibroblast, dendritic cells, and 
monocytes are all part of the mix. Co-cultivation of these cell types into 3D spheroids produce 
protein concentrations analogous to tumors, while 2D models do not."$,"&  
The presence of these ECMs create a significant damper on AuNP delivery in vivo. A 
study preformed at the Indian Institute of Technology in Kanpur showed that the maximum 
achievable efficiency in vivo is only 2%. Although most of the NPs in this study were removed 
by Kupffer cells and other macrophages in the liver, NPs were also observed to pile up around 
the perivascular region. This “stockpile” was counterproductive to the deep diffusion of AuNPs 
into the tumor space because the extracellular matrices of the tumors block NP diffusion in a size 
dependent manner."'   
MCF-7 breast cancer cells are one of the most commonly used breast cancer cell lines for 
research, because they react similarly to breast cancer cells in the body and they can be 
functionalized to be drug resistant to cancer therapies."( They are fairly large adherent cells and 
have a karyotype of 69 chromosomes.") MCF-7 cells have the ability to process estrogen, 
therefore they are estrogen sensitive. The typical cell size of an MCF-7 cell is 20-25 microns and 
typically are cultured in Eagle’s Minimum Essential Medium (EMEM).  When grown in vitro, 
the epithelial like cells of the culture will grow in monolayers while other cells can produce 
dome-like shapes. Spheroid cultivation of MCF-7 cells can be done in a variety of methods 
include ultra-low attachment (ULA) plates and embedment in Matrigel and show better results 
than other cell lines.* Additionally, these methods allow for easy co-culture of MFC-7 cells.   
MCF-7 cells are often manipulated to be drug-sensitive to doxorubicin, a chemotherapy 
drug, or doxorubicin-resistant."* Many studies investigate these drug-differentiated phenotypes 
of MCF-7 cells with their surroundings. One such study is one that was performed by Professor 
Mougel’s team in France; it investigated the effects on immune reactivity of MCF-7 cells by 
monocytes. The study found that, according the phenotype of the breast cancer spheroid, 
monocytes respond with differential recruitment and behavior towards the masses."+ The type of 
monocyte that is of particular interest of those in the immune-reactivity field is a macrophage 
cell. Recent literature suggests that in tumor environments there is an important “cross-talk” that 
is occurring between breast cancer cells and macrophages. Donzelli noted the increase in 
angiogenesis as a result of signaling proteins being exchanged between the two cell types.#, The 
other major constituent of breast cancer stroma is fibroblasts. Research indicates that both 
fibroblasts and macrophages cooperate to organize co-cultures into tumor spheroids in vitro. 
Rama-Esesndagli’s group found that not only was there a higher frequency of spheroids formed 
when using co-cultures rather than just breast cancer cells, but these spheroids also exhibited a 
higher cellular density than their counterparts and are more analogous to each other."& 
 
MATERIALS AND METHODS 
This investigation is multifaceted in terms of experimental setup. First, the proper 
Matrigel concentration for the formation of MCF-7 spheroids must be confirmed. MCF-7 Cells 
will be plated at varying cell concentrations in mediums with varying composition of Matrigel to 
investigate which method most reliably produces spheroids. See the below plate layout for more 
information. 
 
Figure 1: Plate layout for determining optimal Matrigel concentration 
Cell viability will be assessed both optically (through the use of a microscope with the capability 
to take photographs and by using a Cell-Titer Glo 3D Cell Viability assay. The Cell-Titer Glo 3D 
Cell Viability assay will be performed as instructed by Promega, the distributor.  
 The next experiment to be performed will be adding AuNP treated dendritic cells to the 
MCF-7 cells in Matrigel to create a coculture of the two. Dendritic cells will be treated with 
AuNPs per the protocol perfected by another group of undergraduates in Dr. Babensee’s lab. 
(their paper will eventually be linked here, but it has not been published yet). Subsequently, 
macrophages will be added to the coculture and then fibroblasts native to human breast tissue. 
Assays will be conducted to determine cell growth, viability, metastasis, and susceptibility to 
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In the last decade biomaterials have increasingly been studied as the next generation of 
immunotherapeutic treatments for their tendency to induce host response against themselves 
when implanted. Addressing this significant barrier of host response is a key step in engineering 
our immune response to target foreign invaders and diseases such as cancer. A promising 
application of this is gold nanoparticle’s (AuNPs) ability to interact with dendritic cells (DCs) in 
our bodies. 
When the immune system responds to a threat in the body, it initiates a twofold response: 
innate and adaptive immune responses. Each respond simultaneously with different approaches 
to establish immunity in the body, but they ultimately work in partnership with each other to 
optimize the response pathway. While the innate response is immediate and nonspecific to the 
antigens of importance, the adaptive immune response takes several weeks to develop, but 
provides a tailored response to the antigens present. The adaptive immune response functions 
through T and B lymphocytes; allowing the body to retain memory in the form of a chemical 
structure copy of the antigen of importance. This memory allows the body to later elicit a quicker 
response to foreign invader upon subsequent exposure. Using a similar, antigen presenting 
mechanism, dendritic cells of our body are responsible for mediating both of these reaction 
pathways that comprise the immune system." 
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 AuNPs show high potential in the field of immunotherapies because they act as an 
adjuvant to evoke immuno-suppressive or immuno-activated response depending on their 
geometries and ligand coatings. The role of dendritic cells is to work as a gatekeeper to initiating 
immune response in our bodies as they are the most potent antigen presenting cell (APC). In 
previous research, it has been shown that AuNPs can trigger the maturation of immature 
dendritic cells (iDCs) to activated or tolerogenic phenotypes.# 
Researchers continue to fine tune nanoparticle technology for personalized 
immunotherapies and data indicates the efficacy of AuNP in eliciting anti-tumor response by 
providing a superior method to apply targeted vaccinations.$,& As the potential for clinical 
application becomes increasingly apparent, we must dive deeper into the pathophysiology of the 
tumor environment and subsequently question the relevance of these findings.  
Dendritic cells are created and cultivated by differentiation in specific bone marrow cells 
called monocytes.' When an immune response occurs in the body, monocytes will cluster at the 
site of inflammation and systematically develop into immature dendritic cells (iDCs). Their 
major role in the innate and adaptive pathways is the activation of T cells.( Antigens are 
presented to immature dendritic cells, the iDCs phagocytose the antigens, and present the 
antigens on their surface. Once the antigens are presented on the surface of these cells the 
classification changes from immature to mature.) 
The host environments’ interaction with the tumor is one of the most important factors in 
cancer modeling.* In this study we investigate the effectiveness of AuNP application in the 
presence of tumor microenvironment equipped with dendritic cells, macrophages, and 
fibroblasts. We iteratively perform co-cultures of MCF-7 breast cancer cells with every 
combination of these cells in order to create a schematic which will assess applicability of AuNP 
 5 
use in breast cancer models. To make this assessment we will run tests to determine cell growth, 
viability, metastasis, and susceptibility to drugs. An indication of AuNPs working to combat 
cancer cells would be decreased cell growth, viability and metastasis and an increased 
susceptibility to drugs. 
LITERATURE REVIEW 
In the last decade, nanoparticles have been a major area of focus for many researches as 
they show potential to carry and deliver drugs with very specific targeting, due to their low cell 
toxicity. Additionally, they show promise in the augmentation of the maturation of dendritic 
cells. Controlling the phenotype displayed in a mature dendritic cell allows for engineering and 
manipulation of the body’s immune response.+ 
Changes in nanoparticle size, shape, and coating have been shown to majorly skew the 
effectiveness of such treatments. Treated on a wide range of cell types, gold nanoparticles 
(AuNPs) in rod shapes with diameters of approximately 55nm seem to be the most effective in 
cell targeting.", This is a good starting point for functionalization of NPs, but studies indicate 
that they should be further functionalized on a by-cell basis. For example, studies have shown 
that folic acid (FA) increased AuNP uptake in tumor cells because they overexpress folate 
receptors on their surfaces."" As we dig into how the functionalization of a NP determines its 
effectiveness, it becomes clear that the cells’ microenvironment is just as important as cell type, 
if not more important, to determine binding efficiency.  
3D extracellular matrices modulate intercellular interactions such as cell growth and 
metastasis."# Additionally, no tumor cell is purely one cell type. Fibroblast, dendritic cells, and 
monocytes are all part of the mix. Co-cultivation of these cell types into 3D spheroids produce 
protein concentrations analogous to tumors, while 2D models do not."$,"&  
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The presence of these ECMs create a significant damper on AuNP delivery in vivo. A 
study preformed at the Indian Institute of Technology in Kanpur showed that the maximum 
achievable efficiency in vivo is only 2%. Although most of the NPs in this study were removed 
by Kupffer cells and other macrophages in the liver, NPs were also observed to pile up around 
the perivascular region. This “stockpile” was counterproductive to the deep diffusion of AuNPs 
into the tumor space because the extracellular matrices of the tumors block NP diffusion in a size 
dependent manner."'   
MCF-7 breast cancer cells are one of the most commonly used breast cancer cell lines for 
research, because they react similarly to breast cancer cells in the body and they can be 
functionalized to be drug resistant to cancer therapies."( They are fairly large adherent cells and 
have a karyotype of 69 chromosomes.") MCF-7 cells have the ability to process estrogen, 
therefore they are estrogen sensitive. The typical cell size of an MCF-7 cell is 20-25 microns and 
typically are cultured in Eagle’s Minimum Essential Medium (EMEM).  When grown in vitro, 
the epithelial like cells of the culture will grow in monolayers while other cells can produce 
dome-like shapes. Spheroid cultivation of MCF-7 cells can be done in a variety of methods 
include ultra-low attachment (ULA) plates and embedment in Matrigel and show better results 
than other cell lines.* Additionally, these methods allow for easy co-culture of MFC-7 cells.   
MCF-7 cells are often manipulated to be drug-sensitive to doxorubicin, a chemotherapy 
drug, or doxorubicin-resistant."* Many studies investigate these drug-differentiated phenotypes 
of MCF-7 cells with their surroundings. One such study is one that was performed by Professor 
Mougel’s team in France; it investigated the effects on immune reactivity of MCF-7 cells by 
monocytes. The study found that, according the phenotype of the breast cancer spheroid, 
monocytes respond with differential recruitment and behavior towards the masses."+ The type of 
 7 
monocyte that is of particular interest of those in the immune-reactivity field is a macrophage 
cell. Recent literature suggests that in tumor environments there is an important “cross-talk” that 
is occurring between breast cancer cells and macrophages. Donzelli noted the increase in 
angiogenesis as a result of signaling proteins being exchanged between the two cell types.#, The 
other major constituent of breast cancer stroma is fibroblasts. Research indicates that both 
fibroblasts and macrophages cooperate to organize co-cultures into tumor spheroids in vitro. 
Rama-Esesndagli’s group found that not only was there a higher frequency of spheroids formed 
when using co-cultures rather than just breast cancer cells, but these spheroids also exhibited a 
higher cellular density than their counterparts and are more analogous to each other."& 
 
MATERIALS AND METHODS 
This investigation is multifaceted in terms of experimental setup. Figure 1 is a schematic 
that breaks down the experiment into parts of a whole. 
 




First, the proper Matrigel concentration for the formation of MCF-7 spheroids must be 
confirmed. MCF-7 Cells will be plated at varying cell concentrations in mediums with varying 
composition of Matrigel to investigate which method most reliably produces spheroids. While 
the stock solutions of Matrigel are made using a dilution series, preincubate 96-well microtiter 
plates to 37°C. The plates were precoated with 30 μL per well of the relevant matrix. The 
relevant matrix corresponds to the plate layout seen in Figure 2. 
 
Figure 2: Plate layout for determining optimal Matrigel concentration 
The MCF-7 cells were then passaged using Tripsin-EDTA and FBS. Next, cells were diluted to 
the double desired final concentrations as indicated in Figure 2. These discrete concentrations 
were then added to equal parts Matrigel to create the cell and Matrigel concentration indicated in 
the plate layout. Each well receives 60µL of this mixture. For example, to create the 
concentration in well A4 you will add 30µL of 7% Matrigel solution to 30µL of a solution that 
contains 10,000 MCF-7 cells. Cell viability will be assessed both optically (through the use of a 
microscope with the capability to take photographs) and by using a Cell-Titer Glo 3D Cell 
Viability assay. The Cell-Titer Glo 3D Cell Viability assay will be performed as instructed by 
Promega, the distributor.  
 The next experiment to be performed will be adding AuNP treated dendritic cells to the 
MCF-7 cells in Matrigel to create a coculture of the two. Dendritic cells will be treated with 
AuNPs per the protocol perfected by another group of undergraduates in Dr. Babensee’s lab. 
(their paper will eventually be linked here, but it has not been published yet). These AuNP-
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treated dendritic cells will be added to the culture of MCF-7 cells in a ratio of 2:1, a ratio used by 
previous studies.21 As a control, untreated dendritic cells and MCF-7 cells will also be added 
together in a 2:1 ratio. Also both MCF-7 cells and dendritic cells will be seeded alone After this 
study, we will then study the effects of the use of the drug doxorubicin on both cocultures with 
AuNP-dendritic cells and cocultures with containing dendritic cells with no treatment. 
Subsequently, macrophages will be added to the coculture and then fibroblasts will be 
added to the coculture that are native to human breast tissue. Assays will be conducted to 
determine cell growth, viability, metastasis, and susceptibility to drugs under these varying 
conditions.  
 
RESULTS (please note: all of this is hypothetical, we are still testing) 
 Data collected by the Celltiter Glo 3D assay is displayed bellow for each of the 9 testing 
groups.  
An example of what figures 1-9 will look like: 
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Photo images from a few of each category will be organized into a table: 
 Matrigel/Collagen Concentrations 
MCF-7 cells/ Well 
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Cell Count 1% Matrigel/1% 
Collagen 
3.5% Matrigel 3.5% Matrigel/3.5% 
Collagen 
5,000 (image) (image) (image) 
10,000 (image) (image) (image) 
15,000 (image) (image) (image) 
 
This is an example of one of the better spheroids 
 















Sample tables for cocultures 
 














Day MCF-7 DC treatedDC MCF7+ DC MCF-7 + 
treatedDC 
1 Cell count Cell count Cell count Cell count Cell count 
(image) (image) (image) (image) (image) 
3 Cell count Cell count Cell count Cell count Cell count 
(image) (image) (image) (image) (image) 
5 Cell count Cell count Cell count Cell count Cell count 
(image) (image) (image) (image) (image) 
 
Similar tables will follow as fibroblasts and macrophages are added 
 
*ANOVA statistical tests for significance of decrease here* 
 
 
DISSCUSION (please note: all of this is hypothetical, we are still testing) 
Dendritic cells are integral players in the initiation of immune response in the body. 
Research has shown that the application of gold nanoparticles to dendritic cells has a direct 
impact on the phenotypic profiles seen in the DC differentiation process. This change suggests 
that gold nanoparticle-treated dendritic cells are better equip to fight cancer. The experiment we 
conducted put that suggestion to the test on a 3D tumor model. Our data indicates that 3D breast 
cancer spheroids that are grown in 3.5% Matrigel/3.5% collagen gels create the most consistent 
spheroids. Adding AuNP-treated dendritic cells to these 3D breast cancer spheroids yields 
promising results. We found a statistically significant decrease in cell viability and a decrease in 
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cell growth rates. *stats here* These were further decreased when the drug doxorubicin was 
applied to these spheroids. *stats here* 
When fibroblasts are added to the coculture we found that it creates more consistent and 
symmetrical spheroids, also these spheroids responded to being cocultured with AuNP-treated 
dendritic cells more dramatically. *stats on cell viability and growth rate decreasing more that 
that of just MCF-7 + DC spheroids* 
Although the addition of macrophages to the coculture also creates more consistent and 
symmetrical spheroids, these spheroids do not show as impressive of decreases in cell viability 
and growth rate compared to that of just MCF-7 + DC spheroids. *stats*. This indicates that cell-
to-cell interaction between activated dendritic cells and macrophages might be counterproductive 
to the intended effects on the study. Macrophages are widely present near breast cancer tumors 
so this could prove to be a major obstacle. Further research should be done to confirm.  
 
CONCLUSION (please note: all of this is hypothetical, we are still testing) 
AuNP-treated dendritic cells have a significant impact on the slowing of MCF-7 breast cancer 
spheroids growth and viability. The addition of fibroblasts and macrophages to this coculture 
make it a more accurate model of real breast cancer tumors that are found in cancer patients. The 
addition of these cells to the spheroids is integral to an honest evaluation of the effectiveness of 
using AuNP-treated dendritic cells for cancer therapy. Our data indicates that the addition of 
fibroblasts to the coculture makes the treatment more effective, while the addition of 
macrophages to the coculture makes the treatment less effective. This should be explored further 
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